Syngen Biotech Co.,Ltd. (TPEX:8279)

Market Cap	3.85B
Revenue (ttm)	2.03B
Net Income (ttm)	241.60M
Shares Out	27.10M
EPS (ttm)	8.91
PE Ratio	15.94
Forward PE	n/a
Dividend	5.00 (3.69%)
Ex-Dividend Date	Jun 27, 2024

Volume	123,575
Average Volume	27,044
Open	148.00
Previous Close	135.50
Day's Range	139.00 - 148.00
52-Week Range	100.00 - 177.00
Beta	0.11
RSI	76.00
Earnings Date	May 13, 2025

About Syngen Biotech

Syngen Biotech Co.,Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally. The company offers dietary supplements; supplement contract manufacturing services in the form of sachets, liquids, tablets, cup package capsules, jellies, aluminum and glass bottles, and gummies; science-based and bio active pharmaceutical ingredient...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1988
• Employees: 247
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 8279

Financial Performance

In 2024, Syngen Biotech's revenue was 2.01 billion, an increase of 9.60% compared to the previous year's 1.84 billion. Earnings were 240.21 million, a decrease of -12.60%.